Pediatric Systemic Lupus Erythematous in COVID-19 Era.
Viruses
; 15(2)2023 01 18.
Article
in English
| MEDLINE | ID: covidwho-2269986
ABSTRACT
Pediatric systemic lupus erythematosus is a chronic autoimmune disorder with a highly variable course and prognosis. It results in functional abnormalities in the immune system due to intrinsic factors and the use of immunosuppressive therapies associated with underlying comorbidities seem to increase the risk of severe COVID-19 and poor outcomes of the disease in pediatric systemic lupus erythematosus (SLE) patients. The aim of this review is to obtain a better understanding of the existing link between this new viral infection and pediatric lupus. We have analyzed the characteristics of newly diagnosed cases of pediatric SLE following COVID-19 which have been reported in the literature and which describe the impact that COVID-19 has on patients already suffering with pediatric SLE.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
COVID-19
/
Lupus Erythematosus, Systemic
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Humans
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
V15020272
Similar
MEDLINE
...
LILACS
LIS